Advanced Oncotherapy (AVO) – Technological milestones update

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces further notable progress in the manufacture of its first LIGHT system. Patient Positioning System Multiple components of the treatment room have been manufactured, inspected and tested by the Company’s partner P-Cure Ltd., ahead of their integration to form a complete […]

Advanced Oncotherapy (AVO) – Further progress in the technical development of the LIGHT system

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the Company has integrated the proton source and Radio Frequency Quadruple (RFQ), following a successful testing and calibration programme at ADAM, in Geneva. This work has demonstrated there is a predicted acceleration of the proton beam through this very […]

Advanced Oncotherapy – CCL modules ready for high-power testing

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the two Coupled Cavity Linac modules are now ready for high-power testing at the Company’s facility in Geneva. These two modules will be tested at high power by using the Radio Frequency Power Units provided by ScandiNova and Toshiba and it is […]